RxDoctor Payments DataLook up a doctor →

Malcolm Foster, MD

Interventional Cardiology · Knoxville, TNNPI 1861482556

Payments from drug & device makers

$1,913,513in general payments, 2019–2025

Across 1,841 payments — averaging $1039.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$368K
  • CSL Behring$254K
  • American Regent$213K
  • Janssen Research & Development, LLC$130K
  • Novartis$128K
  • Shockwave Medical, Inc$113K
  • plus $707K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott310$368,268
CSL Behring114$254,138
American Regent15$212,796
Janssen Research & Development, LLC31$130,286
Novartis83$127,954
Shockwave Medical, Inc126$112,985
Angiodynamics, Inc.36$109,486
Penumbra, Inc.68$84,989
Amgen121$71,765
Contego Medical, Inc13$53,613
AstraZeneca60$49,400
Amarin Pharma, Inc.48$38,405
Kowa Research Institute, Inc.32$36,834
Surmodics, Inc.45$36,667
Boston Scientific97$32,953
Johnson & Johnson(2 entities)68$29,286
Endotronix, Inc.3$23,382
Bayer10$23,090
Biotronik Inc.114$22,857
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)58$19,242
Esperion Therapeutics, Inc.25$16,424
Astrazeneca UK Limited2$10,124
Inspiremd Ltd1$9,776
Boehringer Ingelheim13$6,997
Inari Medical, Inc.14$6,793
W. L. Gore & Associates, Inc.2$6,025
Ancora Heart, Inc.31$2,863
Merit Medical Systems Inc16$2,849
Microvention, Inc.2$2,760
E.r. Squibb & Sons, L.L.C.18$2,266
Abiomed18$1,556
Novo Nordisk AS49$1,242
Heartflow, Inc.11$727
Silk Road Medical, Inc.5$530
Pfizer37$528
Medtronic(2 entities)23$424
Cvrx, Inc.6$365
Philips North America LLC16$322
Novo Nordisk12$291
Atricure, Inc.7$285
Cardiovascular Systems Inc.11$256
Imperative Care, Inc1$175
Biosense Webster, Inc.5$164
Ablative Solutions, Inc.5$125
Scpharmaceuticals Inc.5$99
Merck6$93
Regeneron Healthcare Solutions, Inc.4$86
Cardinal Health 200 LLC2$81
Kiniksa Pharmaceuticals International, PLC3$77
Astellas Pharma US Inc1$75
Baxter Healthcare4$72
Cardiva Medical, Inc.3$71
Sanofi-aventis U.S. LLC4$68
Edwards Lifesciences3$55
Actelion Pharmaceuticals US, Inc.3$52
Celonova Biosciences, Inc.1$49
Preventice Services, LLC1$48
Teleflex LLC1$38
Endovascular Engineering Inc.4$38
Janssen Scientific Affairs, LLC2$31

How this compares

$1,913,513 in reported general payments places this provider in the 95th percentile of 207 interventional cardiology providers in Tennessee.

See all interventional cardiology providers in Tennessee

Medicare billing

Part B allowed, 2024
$248,325
Medicare patients
1,222
Services billed
2,820

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →